To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies
Clinical trial NCT05866354 · COMPLETED
Trial details
- NCT number
- NCT05866354
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2023-11-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.